1037834-62-0

Basic information

• Product Name: 6-Azaspiro[2.5]octane hydrochloride
• Synonyms: 6-Azaspiro[2.5]octane hydrochloride
• CAS NO: 1037834-62-0
• Molecular Formula: C₇H₁₃N*ClH
• Molecular Weight: 147.64576
• Mol File: 1037834-62-0.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 6-Azaspiro[2.5]octane hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Azaspiro[2.5]octane hydrochloride(1037834-62-0)
• EPA Substance Registry System: 6-Azaspiro[2.5]octane hydrochloride(1037834-62-0)

Safety Data

• Hazardous Substances Data: 1037834-62-0(Hazardous Substances Data)

Usage

General Description

6-Azaspiro[2.5]octane hydrochloride is a chemical compound that belongs to the class of spiro compounds, which contain a bicyclic structure. It is commonly used in the pharmaceutical industry as a precursor in the synthesis of various drugs, particularly those targeted at neurological disorders and mental health conditions. 6-Azaspiro[2.5]octane hydrochloride has also shown potential as a ligand in metal-organic frameworks and as a catalyst in organic synthesis. Additionally, 6-Azaspiro[2.5]octane hydrochloride has been studied for its potential use as a chiral building block in asymmetric synthesis, and its unique structure and properties make it a valuable resource for chemical and pharmaceutical research and development.

Upstream product

• 138163-12-9 benzyl 4-methylene-1-piperidinecarboxylate 
• 20778-47-6 (1-cyanomethyl-cyclopropyl)-acetonitrile 
• 1037834-61-9 N-cbz-6-azaspiro[2.5]octane 

Relevant articles and documents

PYRIMIDINE SULFAMIDE DERIVATIVE AND PREPARATION METHOD AND MEDICAL APPLICATION THEREOF

Disclosed are a series of pyrimidine sulfamide compounds and applications thereof in preparing a drug for a disease related to an ETA receptor antagonist. In particular, disclosed is a derived compound represented by formula (I) or a tautomer or pharmaceutically acceptable composition thereof.

INHIBITORS OF SERINE PALMITOYLTRANSFERASE

This invention provides compounds of the formula (I) useful in the inhibition or modulation of serine palmitoyl transferase and their use in methods of treatment or amelioration of type 2 diabetes, type 1 diabetes, insulin resistance, the effects of obesity, metabolic syndrome (sometimes referred to as Syndrome X), impaired glucose tolerance, Cushing's disease, cardiovascular disease, prothrombotic conditions, myocardial infarction, hypertension, congestive heart failure, cardiomyopathy, atherosclerosis, dyslipidemia, sepsis, liver damage, retinal degenerative disorders, cachexia, emphysema, hepatitis C infections, HIV infections and inflammatory disorders and useful in methods for raising HDL plasma levels in a mammal. The compounds of this invention can also be used to prevent damage or loss of pancreatic islet beta cells (such as in the case of pancreatic beta cell apoptosis, including those related to insulin-dependent diabetes mellitus).